These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8238787)

  • 1. Is tubular apocrine adenoma a distinct clinical entity?
    Ishiko A; Shimizu H; Inamoto N; Nakmura K
    Am J Dermatopathol; 1993 Oct; 15(5):482-7. PubMed ID: 8238787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tubular apocrine adenoma with eccrine and apocrine immunophenotypes or papillary tubular adenoma?
    Tellechea O; Reis JP; Marques C; Baptista AP
    Am J Dermatopathol; 1995 Oct; 17(5):499-505. PubMed ID: 8599457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tubulo-papillary apocrine adenoma in association with syringocystadenoma papilliferum].
    Ayadi L; Mallouli M; Kallel R; Charfi S; Makni S; Boudawara TS; Gouiaa N
    Ann Pathol; 2016 Oct; 36(5):355-357. PubMed ID: 27693311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tubular apocrine adenoma in association with syringocystadenoma papilliferum.
    Aktepe F; Demir Y; Dilek FH
    Dermatol Online J; 2003 Feb; 9(1):7. PubMed ID: 12639465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apocrine type of cutaneous mixed tumor with follicular and sebaceous differentiation.
    Requena L; Sánchez Yus E; Santa Cruz DJ
    Am J Dermatopathol; 1992 Jun; 14(3):186-94. PubMed ID: 1380780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tubular apocrine adenoma and papillary eccrine adenoma. Entities or unity?
    Fox SB; Cotton DW
    Am J Dermatopathol; 1992 Apr; 14(2):149-54. PubMed ID: 1566975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubulopapillary Cystic Adenoma With Apocrine Differentiation: A Unifying Concept for Syringocystadenoma Papilliferum, Apocrine Gland Cyst, and Tubular Papillary Adenoma.
    Ansai SI; Anan T; Fukumoto T; Saeki H
    Am J Dermatopathol; 2017 Nov; 39(11):829-837. PubMed ID: 28033156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syringocystadenoma papilliferum with sebaceous differentiation in an intradermal tubular apocrine component. Report of a case.
    Vazmitel M; Michal M; Mukensnabl P; Kazakov DV
    Am J Dermatopathol; 2008 Feb; 30(1):51-3. PubMed ID: 18212545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syringocystadenoma papilliferum: report of the first case on the lower leg.
    Yoshii N; Kanekura T; Setoyama M; Kanzaki T
    J Dermatol; 2004 Nov; 31(11):939-42. PubMed ID: 15729871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRAF and KRAS mutations in tubular apocrine adenoma and papillary eccrine adenoma of the skin.
    Liau JY; Tsai JH; Huang WC; Lan J; Hong JB; Yuan CT
    Hum Pathol; 2018 Mar; 73():59-65. PubMed ID: 29241739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed tubulopapillary hidradenoma and syringocystadenoma papilliferum occurring as a verrucous tumor.
    Hsu PJ; Liu CH; Huang CJ
    J Cutan Pathol; 2003 Mar; 30(3):206-10. PubMed ID: 12641782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex sweat gland hamartoma: A case report.
    Skopec Z; Berrebi KG; Stone M; Liu V
    J Cutan Pathol; 2023 Mar; 50(3):243-246. PubMed ID: 36323653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case of Syringocystadenoma Papilliferum with Tubular Papillary Adenoma of the Chest.
    Ito K; Ansai SI; Saeki H
    J Nippon Med Sch; 2017; 84(2):79-82. PubMed ID: 28502963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of ductal sweat gland carcinoma connected to syringocystadenoma papilliferum arising in nevus sebaceus.
    Ansai S; Koseki S; Hashimoto H; Hozumi Y; Kondo S
    J Cutan Pathol; 1994 Dec; 21(6):557-63. PubMed ID: 7699123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous leiomyosarcoma, trichoblastoma, and syringocystadenoma papilliferum arising from nevus sebaceus.
    Premalata CS; Kumar RV; Malathi M; Shenoy AM; Nanjundappa N
    Int J Dermatol; 2007 Mar; 46(3):306-8. PubMed ID: 17343592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spectrum of organoid nevi.
    Coskey RJ
    Cutis; 1982 Mar; 29(3):290-2, 294. PubMed ID: 6279360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nevus sebaceous and syringocystadenoma papilliferum.
    Greer KE; Bishop GF; Ober WC
    Arch Dermatol; 1976 Feb; 112(2):206-8. PubMed ID: 183608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syringocystadenoma papilliferum combined with a tubular apocrine adenoma.
    Léda LDSB; Lins MDSVS; Leite EJDS; Cardoso AEC; Houly RLS
    An Bras Dermatol; 2017; 92(5):721-723. PubMed ID: 29166517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case of Tubular Apocrine Adenoma with Syringocystadenoma Papilliferum that Developed in a Nevus Sebaceus.
    Kim MS; Lee JH; Lee WM; Son SJ
    Ann Dermatol; 2010 Aug; 22(3):319-22. PubMed ID: 20711270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pure apocrine nevus. A study of light-microscopic and immunohistochemical features of a rare tumor.
    Ando K; Hashikawa Y; Nakashima M; Nakayama A; Ohashi M
    Am J Dermatopathol; 1991 Feb; 13(1):71-6. PubMed ID: 2003651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.